MedTrace Logo

A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population

NCT04754139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2024-10-03

No results posted yet for this study

Summary

This study aims to use a social media mini-application-enabled intervention to successfully promote the initiation and persistence of pre-exposure prophylaxis (PrEP) among at-risk people 18 years and above (including men who have sex with men (MSM), transgender women, sex workers, and other key populations) in Wuhan and Guangzhou, China.

Conditions

  • HIV Preexposure Prophylaxis

Interventions

OTHER

WeChat mobile mini-application

Sexual health education and the role of PrEP

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • Guangzhou 8th People's Hospital

    collaborator OTHER

  • Social Entrepreneurship to Spur Health

    collaborator OTHER

  • Zhongnan Hospital

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Aniruddha Hazra, MD · University of Chicago

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-24
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04754139 on ClinicalTrials.gov